secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001437749-21-024807
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q1 FY2022 revenue $257.7M, organic growth 21%; adjusted EPS $1.83 vs $1.43
--------------------------------------------------------------------------------

- Q1 FY2022 revenue $257.7M, organic growth 21% (reported 26%).
- GAAP EPS $1.69, adjusted EPS $1.83 vs $1.43 prior year.
- Protein Sciences organic growth 26% (third consecutive quarter >20%).
- China revenue grew over 50% organic; North America and Europe at least 20%.
- Board declared $0.32 per share dividend payable Nov 26, 2021 to holders of record Nov 12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000143774921024807/0001437749-21-024807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000143774921024807/tech20211101_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-024807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer